A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer (Clinical Cancer Research (2014) 20, (3581-3588))

M. D. Galsky, N. J. Vogelzang, P. Conkling, E. Raddad, J. Polzer, S. Roberson

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)4414
Number of pages1
JournalClinical Cancer Research
Issue number16
StatePublished - 15 Aug 2014

Cite this